Enhanced formation and survival of CD4+CD25hi Foxp3+T-cells in chronic lymphocytic leukemia

被引:101
作者
Jak, Margot [1 ,2 ]
Mous, Rogier [1 ,2 ]
Remmerswaal, Ester B. M. [2 ]
Spijker, Rene [1 ,2 ]
Jaspers, Annelieke [1 ,2 ]
Yague, Adriana [1 ]
Eldering, Eric [1 ,2 ]
Van Lier, Rene A. W. [2 ]
Van Oers, Marinus H. J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands
关键词
Chronic lymphocytic leukemia; regulatory T-cells; apoptosis; REGULATORY T-CELLS; NON-HODGKIN-LYMPHOMA; PERIPHERAL-BLOOD; CANCER-PATIENTS; B-CELLS; SUPPRESSIVE FUNCTION; BCL-2; ANTISENSE; CUTTING EDGE; EXPRESSION; APOPTOSIS;
D O I
10.1080/10428190902803677
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, it has been described that patients with chronic lymphocytic leukemia (CLL) have increased numbers of regulatory T (Treg) cells. In the present study, we analysed the mechanism behind Treg cells expansion in CLL. Neither analysis of the T-cell receptor repertoire nor CD45 isoform expression of Treg cells from patients with CLL provided evidence for chronic (tumor) antigenic stimulation as a possible cause for Treg cells expansion in CLL. We found evidence however for increased formation of Treg cells via CD70 costimulation, because we observed that CD40 ligand activated CLL cells (which might be considered a model of lymph node CLL cells) strongly induced CD70-dependent formation of Treg cells. Reverse transcription-multiplex ligation-dependent probe amplification assay expression analysis of 34 apoptosis-regulating genes showed that in comparison with other CD4+ T-cells, Treg cells from both healthy individuals (HD) and patients with CLL had a high expression of pro-apoptotic Noxa and a low expression of anti-apoptotic Bcl-2. Strikingly, Bcl-2 levels of Treg cells in patients with CLL were significantly higher than in HD. Finally, the different apoptotic profile resulted in differences at the functional level, because Treg cells from patients with CLL were more resistant to drug-induced apoptosis than Treg cells from HD. In conclusion, Treg cells in CLL may accumulate both by increased formation, facilitated by CD27-CD70 interaction in the lymph node proliferation centres, and decreased sensitivity to apoptosis because of a shifted Noxa-Bcl-2 balance.
引用
收藏
页码:788 / 801
页数:14
相关论文
共 46 条
  • [1] The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery
    Akbar, Arne N.
    Vukmanovic-Stejic, Milica
    Taams, Leonie S.
    Macallan, Derek C.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2007, 7 (03) : 231 - 237
  • [2] Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation
    Arens, R
    Baars, PA
    Jak, M
    Tesselaar, K
    van der Valk, M
    van Oers, MHJ
    van Lier, RAW
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (10) : 5915 - 5920
  • [3] Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
    Beyer, M
    Kochanek, M
    Darabi, K
    Popov, A
    Jensen, M
    Endl, E
    Knolle, PA
    Thomas, RK
    von Bergwelt-Baildon, M
    Bebey, S
    Hallek, M
    Schultze, JL
    [J]. BLOOD, 2005, 106 (06) : 2018 - 2025
  • [4] Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
    Cesana, GC
    DeRaffele, G
    Cohen, S
    Moroziewicz, D
    Mitcham, J
    Stoutenburg, J
    Cheung, K
    Hesdorffer, C
    Kim-Schulze, S
    Kaufman, HL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1169 - 1177
  • [5] CD4+ CD25+ FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
    Clarke, Sarah L.
    Betts, Gareth J.
    Plant, Andrea
    Wright, Kate L.
    El-Shanawany, Tariq M.
    Harrop, Richard
    Torkington, Jared
    Rees, Brian I.
    Williams, Geraint T.
    Gallimore, Awen M.
    Godkin, Andrew J.
    [J]. PLOS ONE, 2006, 1 (02):
  • [6] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [7] Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways
    Eldering, E
    Spek, CA
    Aberson, HL
    Grummels, A
    Derks, IA
    de Vos, AF
    McElgunn, CJ
    Schouten, JP
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (23) : e153
  • [8] Cutting edge:: In contrast to effector T cells, CD4+CD25+ FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death
    Fritzsching, B
    Oberle, N
    Eberhardt, N
    Quick, S
    Haas, J
    Wildemann, B
    Krammer, PH
    Suri-Payer, E
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (01) : 32 - 36
  • [9] Ghia P, 2002, EUR J IMMUNOL, V32, P1403, DOI 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO
  • [10] 2-Y